ClinVar Miner

Submissions for variant NM_001352514.2(HLCS):c.2341G>A (p.Asp781Asn)

gnomAD frequency: 0.00004  dbSNP: rs149399432
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000674861 SCV001236127 pathogenic Holocarboxylase synthetase deficiency 2024-01-04 criteria provided, single submitter clinical testing This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 634 of the HLCS protein (p.Asp634Asn). This variant is present in population databases (rs149399432, gnomAD 0.006%). This missense change has been observed in individual(s) with holocarboxylase synthetase deficiency (PMID: 12633764, 17274881). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 558569). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt HLCS protein function with a positive predictive value of 80%. This variant disrupts the p.Asp634 amino acid residue in HLCS. Other variant(s) that disrupt this residue have been observed in individuals with HLCS-related conditions (PMID: 11735028), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic.
Myriad Genetics, Inc. RCV000674861 SCV002060376 uncertain significance Holocarboxylase synthetase deficiency 2021-10-20 criteria provided, single submitter clinical testing NM_000411.6(HLCS):c.1900G>A(D634N) is a missense variant classified as a variant of uncertain significance in the context of holocarboxylase synthetase deficiency. D634N has been observed in cases with relevant disease (PMID: 12633764, 17274881, 16134170). Functional assessments of this variant are not available in the literature. D634N has been observed in population frequency databases (gnomAD: AFR 0.01%). In summary, there is insufficient evidence to classify NM_000411.6(HLCS):c.1900G>A(D634N) as pathogenic or benign. Please note: this variant was assessed in the context of healthy population screening.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV002232807 SCV002511496 uncertain significance not specified 2022-04-12 criteria provided, single submitter clinical testing Variant summary: HLCS c.1900G>A (p.Asp634Asn) results in a conservative amino acid change located in the Biotinyl protein ligase (BPL) and lipoyl protein ligase (LPL), catalytic domain of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 251496 control chromosomes. c.1900G>A has been reported in the literature in individuals affected with Holocarboxylase Synthetase Deficiency. These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.
GeneDx RCV003328619 SCV004035702 likely pathogenic not provided 2023-03-10 criteria provided, single submitter clinical testing Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 16134170, 25087612, 12633764, 17274881)
Natera, Inc. RCV000674861 SCV002083720 uncertain significance Holocarboxylase synthetase deficiency 2021-10-13 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.